Track QNCX and 10,000+ stocks
Create a free account to build watchlists, compare peers, and value any stock.
- Build and track watchlists
- Compare against peers
- Earnings & price alerts
No credit card required
Create a free account to build watchlists, compare peers, and value any stock.
No credit card required
QNCX - Quince Therapeutics, Inc. (QNCX) has a earnings per share of $57.60, up 17041.2% over the past year.
Latest EPS (Actual)
$57.60
Beat Rate
14.3%
Most Recent
Beat
| Date | Estimated EPS | Actual EPS | Result | Surprise % |
|---|---|---|---|---|
| May 2026 | -$52.00 | $57.60 | Beat | +210.77% |
| Mar 2026 | -$0.18 | -$0.41 | Miss | -123.35% |
| Nov 2025 | -$0.22 | -$0.25 | Miss | -13.64% |
| Aug 2025 | -$0.26 | -$0.34 | Miss | -30.77% |
| May 2025 | -$0.23 | -$0.34 | Miss | -47.83% |
| Mar 2025 | -$0.10 | -$0.28 | Miss | -183.90% |
| Nov 2024 | -$0.10 | -$0.13 | Miss | -27.20% |
Earnings per share (EPS) is a company's net profit divided by its number of outstanding shares. It shows how much profit is attributable to each share and is one of the most closely watched gauges of profitability.